Genome-wide association studies (GWAS) have identified a number of genetic risk variants for NAFLD, including PNPLA3 rs738409 and TM6SF2 rs58542926, both of which have robust associations with disease phenotypes via functional pathobiological pathways.2 The gene discussed is TM6SF2; the disease is metabolic dysfunction-associated steatotic liver disease.